Differential expression pattern of estrogen receptors, aromatase, and sulfotransferase in breast cancer tissue and corresponding lymph node metastases

Tumor Biology

Volumn 32, Issue 3, 2011, Pages 501-508

  Gschwantler Kaulich, Daphne ^a   Fink Retter, Anneliese ^a   Czerwenka, Klaus ^b   Hudelist, Gernot ^a,c   Kaulich, Axel ^a   Kubista, Ernst ^a,b   Singer, Christian F ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c Villach Medical Center   (Austria)

Author keywords

Aromatase; Breast cancer; Estrogen receptor; Estrogen sulfotransferase; Lymph node metastases

Indexed keywords

AROMATASE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGEN SULFOTRANSFERASE; ESTROGEN RECEPTOR; SULFOTRANSFERASE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER HORMONE THERAPY; CANCER INVASION; CANCER RESISTANCE; CANCER TISSUE; CLINICAL ARTICLE; DISEASE ASSOCIATION; EPITHELIUM CELL; HORMONE RESISTANCE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; PILOT STUDY; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STROMA CELL; TREATMENT RESPONSE; BREAST TUMOR; CHEMISTRY; FEMALE; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; AROMATASE; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MIDDLE AGED; RECEPTORS, ESTROGEN; SULFOTRANSFERASES;

EID: 79960589492     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-010-0144-3     Document Type: Article

References (32)

1. Schiff R, Massarweh S, Shou J, et al. Breast cancer endocrine resistance: how growth factor signaling and estrogen receptor coregulators modulate response. Clin Cancer Res. 2003;9:447-54.
2. Bedard PL, Freedman OC, Howell A, et al. Overcoming endocrine resistance in breast cancer: are signal transduction inhibitors the answer? Breast Cancer Res Treat. 2008;108:307-17. (Pubitemid 351431070)
3. Hudelist G, Czerwenka K, Keckstein J, et al. Expression of aromatase and estrogen sulfotransferase in eutopic and ectopic endometrium: evidence for unbalanced estradiol production in endometriosis. Reprod Sci. 2007;14:798-805. (Pubitemid 351903565)
4. Abul-Hajj YJ, Iverson R, Kiang DT. Aromatization of androgens by human breast cancer. Steroids. 1979;33:205-22. (Pubitemid 9135767)
5. Lipton A, Santner SJ, Santen RJ, et al. Aromatase activity in primary and metastatic human breast cancer. Cancer. 1987;59:779-82. (Pubitemid 17018756)
6. Suzuki T, Miki Y, Nakamura Y, et al. Sex steroid-producing enzymes in human breast cancer. Endocr Relat Cancer. 2005;12:701-20. (Pubitemid 41815772)
7. Zhang H, Varlamova O, Vargas FM, Falany CN, Leyh TS. Sulfuryl transfer: the catalytic mechanism of human estrogen sulfotransferase. J Biol Chem. 1998;273:10888-92. (Pubitemid 28204925)
8. Geisler J. Breast cancer tissue estrogens and their manipulation with aromatase inhibitors and inactivators. J Steroid Biochem Mol Biol. 2003;86:245-53. (Pubitemid 37420000)
9. Geisler J, Lønning PE. Aromatase inhibition: translation into a successful therapeutic approach. Clin Cancer Res. 2005;11:2809-21. (Pubitemid 40525179)
10. Sasano H, Nagura H, Harada N, Goukon Y, Kimura M. Immunolocalization of aromatase and other steroidogenic enzymes in human breast disorders. Hum Pathol. 1994;25:530-5. (Pubitemid 24173872)
11. Sasano H, Frost AR, Saitoh R, et al. Aromatase and 17 beta-hydroxysteroid dehydrogenase type 1 in human breast carcinoma. J Clin Endocrinol Metabol. 1996;81:4042-6. (Pubitemid 26380415)
12. Remmele W, Stegner HE. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe. 1987;8:138-40.
13. Hudelist G, Wülfing P, Kersting C. Expression of aromatase and estrogen sulfotransferase in preinvasive and invasive breast cancer. J Cancer Res Clin Oncol. 2008;134:67-73. (Pubitemid 350060686)
14. Kristek J, Dmitrovic B, Kurbel S, et al. Tumor growth fraction, expression of estrogen and progesterone receptors, p53, bcl-2 and cathepsin D activity in primary ductal invasive breast carcinoma and their axillary lymph node metastases. Coll Antropol. 2007;31:1043-7.
15. Harrell JC, Dye WW, Harvell DM, et al. Estrogen insensitivity in a model of estrogen receptor positive breast cancer lymph node metastasis. Cancer Res. 2007;67:10582-91. (Pubitemid 350070835)
16. Speirs V, Parkes AT, Kerin MJ, et al. Coexpression of estrogen receptor alpha and beta: poor prognostic factors in human breast cancer? Cancer Res. 1999;59:525-8. (Pubitemid 29076043)
17. Rosa FE, Caldeira JR, Felipes J, et al. Evaluation of estrogen receptor alpha and beta and progesterone receptor expression and correlation with clinicopathologic factors and proliferative marker Ki-67 in breast cancers. Hum Pathol. 2008;39:720-30.
18. Vinayagam R, Sibson DR, Holcombe C, Aachi V, Davies MP. Association of oestrogen receptor beta 2 (ER beta 2/ER beta cx) with outcome of adjuvant endocrine treatment for primary breast cancer-a retrospective study. BMC Cancer. 2007;7:131.
19. Esslimani-Sahla M, Simony-Lafontaine J, Kramar A, et al. Estrogen receptor beta (ER beta) level but not its ER beta cx variant helps to predict tamoxifen resistance in breast cancer. Clin Cancer Res. 2004;10:5769-76. (Pubitemid 39180954)
20. Cappelletti V, Celio L, Bajetta E, et al. Prospective evaluation of estrogen receptor-beta in predicting response to neoadjuvant antiestrogen therapy in elderly breast cancer patients. Endocr-Relat Cancer. 2004;11:761-70. (Pubitemid 40065549)
21. Silva MC, Rowlands MG, Dowsett M, et al. Intratumoral aromatase as a prognostic factor in human breast carcinoma. Cancer Res. 1989;49:2588-91. (Pubitemid 19143382)
22. Miller WR, Anderson TJ, Jack WJ. Relationship between tumor aromatase activity, tumor characteristics and response to therapy. J Steroid Biochem Mol Biol. 1990;37:1055-9.
23. Miller WR. Aromatase activity in breast tissue. J Steroid Biochem Mol Biol. 1991;39:783-90.
24. Bolufer P, Ricart E, Lluch A, et al. Aromatase activity and estradiol in human breast cancer: its relationship to estradiol and epidermal growth factor receptors and to tumor-node-metastasis staging. J Clin Oncol. 1992;10:438-46.
25. Lipton A, Santen RJ, Santner SJ, Harvey HA, Sanders SI, Matthews YL. Prognostic value of breast cancer aromatase. Cancer. 1992;70:1951-5.
26. Santner SJ, Feil PD, Santen RJ. In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway. J Clin Endocrinol Metab. 1984;59:29-33. (Pubitemid 14087520)
27. Purohit A, Newman SP, Reed MJ. The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer. Breast Cancer Res. 2002;4:65-9. (Pubitemid 34248122)
28. Esteban JM, Warsi Z, Haniu M, Hall P, Shively JE, Chen S. Detection of intratumoral aromatase in breast carcinomas. An immunohistochemical study with clinicopathologic correlation. Am J Pathol. 1992;140:337-43.
29. Lu Q, Nakmura J, Savinov A, et al. Expression of aromatase protein and messenger ribonucleic acid in tumor epithelial cells and evidence of functional significance of locally produced estrogen in human breast cancers. Endocrinology. 1996;137:3061-8. (Pubitemid 26192205)
30. Brodie AM, Lu Q, Long BJ, et al. Aromatase and COX-2 expression in human breast cancers. J Steroid Biochem Mol Biol. 2001;79:41-7. (Pubitemid 34158777)
31. Miki Y, Suzuki T, Tazawa C, et al. Aromatase localization in human breast cancer tissues: possible interactions between intra-tumoral stromal and parenchymal cells. Cancer Res. 2007;67:3945-54. (Pubitemid 46762184)
32. Suzuki T, Nakata T, Miki Y, et al. Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma. Cancer Res. 2003;63:2762-70. (Pubitemid 36667146)